TherapeuticsMD, Inc. financial data

Symbol
TXMD on Nasdaq
Industry
Pharmaceutical Preparations
Location
951 Yamato Road, Suite 220, Boca Raton, FL
State of incorporation
NV
Fiscal year end
December 31
Former names
AMHN, Inc. (to 9/14/2011), CROFF ENTERPRISES INC (to 9/4/2009), CROFF OIL CO (to 4/1/1997)
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 134 % +166%
Debt-to-equity 71.8 %
Return On Equity -21.4 % -106%
Return On Assets -19.9 % -122%
Operating Margin 59.9 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.6M shares +0.36%
Common Stock, Shares, Outstanding 11.5M shares 0%
Entity Public Float 13.4M USD -61.1%
Common Stock, Value, Issued 11K USD 0%
Weighted Average Number of Shares Outstanding, Basic 11.5M shares +12.8%
Weighted Average Number of Shares Outstanding, Diluted 11.5M shares +12.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 69.4M USD +246%
Operating Income (Loss) -2.44M USD +1.29%
Nonoperating Income (Expense) 1.39M USD +2297%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.05M USD +56.5%
Net Income (Loss) Attributable to Parent -6.09M USD -114%
Earnings Per Share, Basic -0.09 USD/shares +62.5%
Earnings Per Share, Diluted -0.09 USD/shares +62.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.06M USD +16.9%
Assets, Current 12.3M USD +3.93%
Property, Plant and Equipment, Net 19K USD -96.6%
Operating Lease, Right-of-Use Asset 6.1M USD -11.2%
Intangible Assets, Net (Excluding Goodwill) 4.32M USD -29.1%
Other Assets, Noncurrent 130K USD +124%
Assets 38.8M USD -10.4%
Accounts Payable, Current 258K USD +856%
Employee-related Liabilities, Current 118K USD -84.5%
Liabilities, Current 5.17M USD -24.6%
Operating Lease, Liability, Noncurrent 5.54M USD -15.2%
Other Liabilities, Noncurrent 744K USD +17%
Liabilities 11.5M USD -18.3%
Retained Earnings (Accumulated Deficit) -952M USD -0.23%
Stockholders' Equity Attributable to Parent 27.4M USD -6.55%
Liabilities and Equity 38.8M USD -10.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.7M USD +51.3%
Common Stock, Shares Authorized 32M shares +167%
Common Stock, Shares, Issued 11.5M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.06M USD +16.9%
Operating Lease, Liability 7.18M USD -10.4%
Depreciation 100K USD -83.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.3M USD -109%
Lessee, Operating Lease, Liability, to be Paid 8.95M USD -14.2%
Property, Plant and Equipment, Gross 2.52M USD -0.04%
Operating Lease, Liability, Current 1.63M USD +10.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.55M USD +2.51%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.51M USD +2.44%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.77M USD -26.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.59M USD +2.52%
Deferred Tax Assets, Operating Loss Carryforwards 167M USD +5.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.63M USD +2.52%
Additional Paid in Capital 979M USD
Depreciation, Depletion and Amortization 180K USD +40.6%
Share-based Payment Arrangement, Expense 1.3M USD -88.8%
Interest Expense 300K USD +50%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%